Max Chan
Director of Finance/CFO bei FORESEE PHARMACEUTICALS CO., LTD.
Profil
Max Chan is currently a Member-Supervisory Board at Wisepal Technologies, Inc., Harvest Investments Ltd., Himax Imaging Ltd., Himax Media Solutions, Inc., Himax Taiwan, Inc., Himax Semiconductor Ltd., Eden Biologics, Inc., and Foresee Pharmaceuticals Co., Ltd.
He previously worked as a Manager-Intel Capital Treasury at Intel Corp., Manager-Overseas Direct Investment Department at CDIB Capital Group, Chief Financial Officer at Himax Technologies, Inc., CFO, Head-Finance & Administration at TaiGen Biotechnology Co., Ltd., Senior Associate at Credit Suisse First Boston Asia International (Cayman) Ltd., and Deputy General Manager & Head-Finance at OBI Pharma, Inc. Mr. Chan received a graduate degree from the University of Illinois and undergraduate and MBA degrees from National Taiwan University.
Aktive Positionen von Max Chan
| Unternehmen | Position | Beginn |
|---|---|---|
| JHL BIOTECH, INC. | Comptroller/Controller/Auditor | 20.10.2015 |
| FORESEE PHARMACEUTICALS CO., LTD. | Director of Finance/CFO | 07.10.2019 |
| Himax Taiwan, Inc. | Director of Finance/CFO | 08.03.2010 |
| Himax Media Solutions, Inc. | Director/Board Member | 08.03.2010 |
| Himax Imaging Ltd. | Director/Board Member | 08.03.2010 |
Wisepal Technologies, Inc.
 Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The private company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Director/Board Member | 08.03.2010 |
| Harvest Investments Ltd. | Director/Board Member | 09.12.2010 |
| Himax Semiconductor Ltd. | Director/Board Member | 09.12.2010 |
Ehemalige bekannte Positionen von Max Chan
| Unternehmen | Position | Ende |
|---|---|---|
| OBI PHARMA, INC. | Director of Finance/CFO | 01.01.2019 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Max Chan
| University of Illinois | Graduate Degree |
| National Taiwan University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| INTEL CORPORATION | Electronic Technology |
| HIMAX TECHNOLOGIES, INC. | Electronic Technology |
| OBI PHARMA, INC. | Health Technology |
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
CDIB Capital Group
 CDIB Capital Group Investment ManagersFinance CDIB Capital Group engages in the venture capital, and investment banking industries. Its business activities include industrial investment, asset management, own capital investment assets, activated assets, and international investment. The company was founded in 1959 and is headquartered in Taipei, Taiwan. | Finance |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Wisepal Technologies, Inc.
Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The private company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Distribution Services |
| Harvest Investments Ltd. | |
| Himax Imaging Ltd. | |
| Himax Media Solutions, Inc. | |
| Himax Taiwan, Inc. | |
| Himax Semiconductor Ltd. | |
| Credit Suisse First Boston Asia International (Cayman) Ltd. | |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
